T 1255/11 (Medium chain triglycerides in the treatment of Alzheimer's disease/ACCERA) of 29.11.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T125511.20171129
- Date of decision
- 29 November 2017
- Case number
- T 1255/11
- Online on
- 28 February 2018
- Petition for review of
- -
- Application number
- 01930965.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF MEDIUM CHAIN TRIGLYCERIDES FOR THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE
- Applicant name
- Accera, Inc.
- Opponent name
- Lupton, Frederick
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Remittal to the department of first instance - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.